Slow Capital Inc. raised its stake in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 1.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,210 shares of the financial services provider’s stock after buying an additional 128 shares during the period. Slow Capital Inc.’s holdings in CME Group were worth $1,876,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in the business. Meridian Wealth Advisors LLC increased its position in shares of CME Group by 1.3% during the 3rd quarter. Meridian Wealth Advisors LLC now owns 3,483 shares of the financial services provider’s stock valued at $674,000 after purchasing an additional 46 shares during the period. Exchange Capital Management Inc. boosted its stake in CME Group by 2.1% during the fourth quarter. Exchange Capital Management Inc. now owns 2,437 shares of the financial services provider’s stock valued at $557,000 after buying an additional 49 shares in the last quarter. Veriti Management LLC grew its holdings in CME Group by 1.0% during the fourth quarter. Veriti Management LLC now owns 5,327 shares of the financial services provider’s stock worth $1,217,000 after acquiring an additional 52 shares during the period. Kestra Private Wealth Services LLC raised its position in CME Group by 2.9% in the fourth quarter. Kestra Private Wealth Services LLC now owns 1,873 shares of the financial services provider’s stock worth $428,000 after acquiring an additional 53 shares in the last quarter. Finally, Alera Investment Advisors LLC lifted its holdings in CME Group by 2.1% in the 4th quarter. Alera Investment Advisors LLC now owns 2,976 shares of the financial services provider’s stock valued at $680,000 after acquiring an additional 61 shares during the last quarter. Institutional investors own 84.58% of the company’s stock.
A number of analysts recently commented on CME shares. Rosenblatt Securities dropped their target price on shares of CME Group from $268.00 to $267.00 and set a “neutral” rating on the stock in a report on Thursday, April 14th. Compass Point increased their price objective on CME Group from $235.00 to $250.00 and gave the company a “neutral” rating in a research report on Thursday, February 10th. Citigroup raised their price objective on CME Group from $275.00 to $280.00 in a research note on Thursday. Morgan Stanley boosted their target price on CME Group from $255.00 to $271.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 13th. Finally, Bank of America increased their price target on CME Group from $244.00 to $252.00 and gave the company an “underperform” rating in a research report on Thursday, February 10th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $254.75.
CME Group (NASDAQ:CME – Get Rating) last announced its quarterly earnings results on Wednesday, April 27th. The financial services provider reported $2.11 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.11. CME Group had a return on equity of 9.29% and a net margin of 57.98%. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the company earned $1.79 EPS. The firm’s revenue was up 7.4% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post 7.84 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, March 25th. Stockholders of record on Thursday, March 10th were paid a dividend of $1.00 per share. This is a positive change from CME Group’s previous quarterly dividend of $0.90. The ex-dividend date was Wednesday, March 9th. This represents a $4.00 annualized dividend and a dividend yield of 1.82%. CME Group’s dividend payout ratio is 52.22%.
In other CME Group news, insider Sean Tully sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, March 14th. The stock was sold at an average price of $229.80, for a total transaction of $919,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kevin Kometer sold 13,500 shares of the stock in a transaction that occurred on Thursday, February 10th. The shares were sold at an average price of $244.04, for a total value of $3,294,540.00. The disclosure for this sale can be found here. Insiders have sold a total of 32,650 shares of company stock worth $7,814,564 in the last 90 days. 0.30% of the stock is owned by insiders.
About CME Group (Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.